K-numberK243227
Device nameB-Scan
ApplicantAccutome, Inc. Doing Business AS Keeler USA
Product codeIYO
Device classClass II
Decision dateJul 11, 2025
DecisionSubstantially Equivalent
Regulation892.1560
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The B-Scan is an ultrasound imaging device that uses pulsed echo technology to visualize the internal structure of the eye, including opaque media and posterior pathology. It is intended for diagnosing pathological or traumatic eye conditions in both adult and pediatric patients and is used by trained ophthalmic professionals.

Technological characteristics

The subject device has a hyperbolic paraboloid membrane profile (vs. flat), operates at 12 MHz nominal frequency, achieves 60 mm depth penetration with fixed gain (0-112 dB) and fixed frequency, supports USB 2 and 3 connectivity, and uses transducer calibration stored in EEPROM at the scan head. Minor differences include increased sampling rate (4096 vs. 2048 points per line), slightly different frame rates, and enhanced cybersecurity in the user interface, while core clinical algorithms remain identical to the predicate.

Test standards cited

IEC 60601-1 (electrical safety), IEC 60601-1-2 (EMC), IEC 60601-2-37 (ultrasound devices), ISO 10993 series (biocompatibility testing including cytotoxicity, ocular irritation, and skin sensitization). Bench testing included accelerated thermal cycling, UV assessment, transit performance, USB pull testing, and repeated reprocessing validation.

Substantial equivalence argument

The subject device has identical indications for use, intended user profile, and clinical purpose as the predicate B-Scan Plus. Although technological characteristics differ (membrane profile, interface enhancements, transducer calibration storage location), these differences do not raise new safety or effectiveness questions because all critical clinical functions use the same algorithms, the device operates in the same clinical environment, biocompatibility and performance testing meet or exceed predicate specifications, and the subject device demonstrates equivalent or superior safety and effectiveness to the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →